Toxoplasmosis other diagnostic studies

Jump to navigation Jump to search

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis other diagnostic studies

CDC on Toxoplasmosis other diagnostic studies

Toxoplasmosis other diagnostic studies in the news

Blogs on Toxoplasmosis other diagnostic studies

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Other Diagnostic Studies

The diagnosis of toxoplasmosis cna be established by:

  • Observation of parasites in patient specimens, such as bronchoalveolar lavage material from immunocompromised patients, or lymph node biopsy.
  • Isolation of parasites from blood or other body fluids, by intraperitoneal inoculation into mice or tissue culture. The mice should be tested for the presence of Toxoplasma organisms in the peritoneal fluid 6 to 10 days post inoculation; if no organisms are found, serology can be performed on the animals 4 to 6 weeks post inoculation.
  • Detection of parasite genetic material by PCR, especially in detecting congenital infections in utero.
  • Serologic testing is the routine method of diagnosis, because the techniques described above are technically complex and generally not rewarding.

There is an algorithm for the immunodiagnosis of toxoplasmosis for individuals greater than one year of age.

  • The IFA and EIA tests for IgG and IgM antibodies are the tests most commonly used today.
  • Persons should be initially tested for the presence of Toxoplasma-specific IgG antibodies to determine their immune status.
  • A positive IgG titer indicates infection with the organism at some time. If more precise knowledge of the time of infection is necessary, then an IgG positive person should have an IgM test performed by a procedure with minimal nonspecific reactions, such as IgM-capture EIA.
  • A negative IgM test essentially excludes recent infection, but a positive IgM test is difficult to interpret because Toxoplasma-specific IgM antibodies may be detected by EIA for as long as 18 months after acute acquired infection.

References


Template:WikiDoc Sources